Login / Signup

Real-life experience with high-frequency chest wall oscillation vest therapy in adults with non-cystic fibrosis bronchiectasis.

Tara Lynn BartoDiego Jose MaselliSarah DaignaultJohn StiglichJared PorterCarlye KraemerGary Hansen
Published in: Therapeutic advances in respiratory disease (2021)
NCFB patients showed improved self-reported outcomes associated with the initiation of HFCWO therapy as measured by number of hospitalizations, antibiotic use, and the subjective experience of airway clearance. The improvement was observed early on after initiation of therapy and sustained for at least 1 year. The reviews of this paper are available via the supplemental material section.
Keyphrases